Adhesion and spreading ofcultured human umbilical vein endothelial cells on fibrin surfaces of varying structure were characterized to understand better the interactions occurring between endothelium and fibrin at sites of vascular injury. Fibrin prepared with reptilase, which cleaves only fibrinopeptide A from fibrinogen, and fibrin prepared with thrombin, which cleaves both fibrinopeptide A and fibrinopeptide B, equally supported endothelial cell adhesion. In contrast, only fibrin made with thrombin mediated endothelial cell spreading, as assessed by fluorescence microscopy of cells stained with rhodamine phalloidin to identify actin stress fibers or by scanning electron microscopy. Fibrin prepared with reptilase failed to support cell spreading. To further investigate the role of the amino terminus of the fibrin 6 chain after fibrinopeptide B cleavage in promoting cell spreading, protease III from Crotalus atrox venom was used to specifically cleave the amino-terminal 42 residues of the fibrinogen B,) chain. After clotting with thrombin, this fibrin derivative lacking B#1-42 failed to support significant cell spreading. Spreading on fibrin was unaffected by depletion of Weibel-Palade bodies from endothelial cells, indicating that the spreading was independent of stimulated von Willebrand factor release. We conclude that endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and involves residues 1542 of the fibrin 8 chain. (J. Clin. Invest.
Introduction
Blood vessels are lined with a confluent monolayer ofendothelial cells (EC)' that are polarized, with their luminal surface exposed to flowing blood and their abluminal side adherent to subendothelial matrix proteins. Cultured EC adhere and spread on purified, surface-bound glycoproteins found in the subendothelium including fibronectin (1-3), collagen (1, 3) , laminin (2) (3) (4) (5) , vitronectin (1, 6) , thrombospondin (7, 8) , and von Willebrand factor (vWf) (6, 9) . Also, surfaces coated with fibrinogen mediate EC adhesion in vitro (1, 3, 9-1 1), although fibrinogen is primarily a plasma protein and not normally a component of the subendothelial matrix. Exposure ofthe subendothelium to fibrinogen occurs only with vessel injury which also causes activation of the coagulation system, resulting in conversion of plasma fibrinogen to fibrin. The interaction of EC with fibrin results in several effects including cell retraction and loss of cell organization (12, 13) , separation of the monolayer into migratory cells (13) , and release ofvWffrom WeibelPalade bodies (14) . However, less is known about the mechanism mediating EC adhesion or spreading on fibrin, which is essential to the processes of wound healing and revascularization.
Adhesion and spreading of EC on protein substrates are related but separate cell functions. Adhesion is mediated through binding of transmembrane, heterodimer glycoprotein cell surface receptors, termed integrins, to specific sites on adhesive glycoproteins containing the tripeptide amino acid sequence, arginine-glycine-aspartic acid (RGD) (15). Endothelial cells express multiple integrins including a#3, which mediates adhesion to a number of glycoproteins including vitronectin, thrombospondin, vWf, and fibrinogen (6, 7, 9, 16) . Cell spreading requires initial adhesion, followed by cytoskeletal organization including the formation of stress fiber bundles composed of actin filaments. These actin filaments are connected to the plasma membrane through a sequence ofcytoplasmic proteins which bind to the intracellular segment ofthe integrin receptor at the focal contact or adhesion plaque (17) . Sequential cytoskeletal organizational changes including extrusion of lamellipodia adjacent to the site of injury, relocation of the centrosome, elongation ofthe cell in a polarized manner, and formation of actin stress fibers have been described in vitro at sites of endothelial injury (18) . Such cytoskeletal changes contribute to spreading and migration, and they are important events in the response to vessel injury, as adherent EC adjacent to the damaged de-endothelialized area are stimulated to cover the exposed subendothelium or to revascularize fibrin clots.
In the present study we have investigated the structural features of fibrin required to mediate EC spreading, using several enzymes to prepare fibrin substrates varying in structure at critical locations. Thrombin cleaves fibrinogen at argl6-glyl7 of the Aa chain and argl4-glyl 5 19, 20) . The polypeptide chain composition offibrinogen and fibrin was assessed by 7% SDS PAGE after disulfide bond reduction as described (23) . Human thrombin (3,250 U/mg), which cleaves both FPA and FPB, and reptilase snake venom, which cleaves only FPA, were obtained from Calbiochem-Behring Corp., LaJolla, CA, and from American Diagnostica, respectively. For some experiments, thrombin was 125I radiolabeled using the lacto-peroxidase method (24) to a specific activity of 2.3 X 108 cpm/mg, and the labeled thrombin retained 82% activity as determined by chromogenic assay using the chromo-
Cell culture. Human umbilical vein EC were harvested as described elsewhere (25, 26) , cultured in McCoy's 5A medium (TCN/Flow Laboratories, McLean, VA) with 20% fetal bovine serum, and passaged up to five times, although most experiments used second passage cells.
Passaged cells were supplemented with 50 gg/ml EC growth supplement (Biomedical Technologies, Inc., Stoughton, MA) and 10 ,g/ml heparin (Sigma Chemical Co., St. Louis, MO). Near-confluent cells were metabolically labeled overnight with 25 MCi/ml of [35S]cysteine (1,153.4 Ci/mol, New England Nuclear Research Products, Boston, MA) in complete culture medium. EC suspensions used in adhesion and spreading studies were prepared by trypsinization of the monolayers. Cells were suspended by rinsing in Hank's balanced salt solution (HBSS) followed by brief incubation with trypsin-EDTA (Gibco Life Technologies, Inc., Grand Island, NY) and diluted 1:1 with HBSS (final concentration, 0.125% trypsin, 0.25 mM EDTA). This was followed by centrifugation (300 g, 5 min) and resuspension three times using McCoy's 5A medium in the absence of serum. The EC were resuspended to an approximate concentration of 2 X I05 cells/ml. Primary human foreskin fibroblasts were prepared by finely mincing a newborn foreskin, digesting for 30-90 min in trypsin-EDTA at 37°C
and plating of resulting cell suspension in a 25-cm2 cell culture flask.
Studies were conducted using fibroblast cultures at less than two passages.
Cell adhesion. l-ml wells of 24-well cell culture plates (Corning Glass Works, Corning, NY), were coated by incubation with 0.4 ml of 30 ,g/ml human plasma fibronectin, 60 (27) , or I gg/ml D-phenylalanyl-L-prolyl-L-arginyl-chloromethyl ketone (PPACK) (Bachem California, Torrence, CA), a synthetic, highly specific thrombin inhibitor (27, 28) staining of cells with anti-von Willebrand factor antiserum was performed as previously described (24) . vWf was immunopurified from cell lysates or culture medium samples using previously described methods (29) . The immunopurified vWf was electrophoresed on SDS 2% agarose gels (30) and the multimeric composition was determined after autoradiography.
Statistics. Comparison of means was performed using the twotailed Student's t test. Variance is described as ±SEM.
Results
EC plated onto fibrin made with thrombin were well-spread after 2 h showing clearly defined stress fibers traversing the cell in a bidirectional orientation and extending to the leading edge of the cell (Fig. 1 a) . In contrast, cells remained unspread on fibrin prepared with reptilase ( Fig. 1 b) , and appeared smaller and lacked organized stress fibers. In the unspread cells, some actin filaments were noted with no apparent orientation at the cell periphery, and there were occasional small bleblike projections extending from the cell surface. A similar spreading pattern on the two types of fibrin was observed with early passage fibroblasts (not shown). These findings were confirmed by scanning electron microscopy which showed that EC on thrombin-made fibrin were well spread with several long filamentous surface projections extending from the cell (Fig. 2 a) . The unspread EC on fibrin made with reptilase showed no orientation and were more spherical with small spikelike projections extending from their surface in many directions (Fig. 2  b) . The fine fibrillar background ofthe fibrin surface made with thrombin or reptilase was seen, and occasional larger fibrin bundles were present. The difference in spreading pattern was also observed by light microscopy with EC plated on 2-mmthick clots.
Cell spreading was quantitated as the percent of adherent cells showing well-defined stress fiber development (Fig. 3) . Spreading of 70±4% of EC occurred on fibrin made with thrombin, and this was significantly greater than the 3±2% spreading of cells adherent to fibrin prepared with reptilase (P < 0.0005). Fibrin prepared initially with reptilase and then incubated with thrombin resulted in a clot surface promoting Figure 1 . Fluorescent micrograph of EC stained for F-actin with rhodamine phalloidin. Slides were coated with fibrin by brief incubation with fibrinogen (3 mg/ml), and either thrombin (0.5 U/ml) or reptilase (0.5 U/ml). A (Fig. 3 ). EC were also tested for adhesion and spreading on control substrate coatings of BSA (60 mg/ml), fibronectin (30 gg/ml), and fibrinogen (3 mg/ml).
There was 3±1% adhesion and 0% spreading of EC on a BSA coated surface, 43±3% adhesion and 93±2% spreading on the fibronectin coated surface and 21±2% adhesion and 32±10% spreading on the fibrinogen-coated surface.
The polypeptide chain composition of the various fibrin preparations was characterized by SDS PAGE (Fig. 4) Gelatin sepharose chromatography and immunoadsorption were used to reduce the fibronectin concentration to < 0. 6 ,gg/ml in the fibrinogen solutions used to prepare clots. To determine whether an increase in fibronectin content of clots would cause an increase in cell spreading, purified fibronectin (30 ,ug/ml) was added to the fibrinogen solutions used to prepare fibrin clots. In paired experiments, thrombin-made fibrin prepared from factor XIII-inactivated, fibronectin-depleted fibrinogen supported 91±4% EC spreading as compared with 80±4% spreading on thrombin-made fibrin prepared from fibrinogen to which 30 ,g/ml fibronectin was added. Similarly, there was no EC spreading on reptilase-made fibrin (0%) and on fibrin made by reptilase cleavage of fibrinogen containing supplemental fibronectin (0%1), although cell adhesion was similar on both clots at 55±3% and 52±2%, respectively. Additionally, treatment of fibronectin (30 Ag/ml) by 0.5 U/ml of reptilase resulted in a coating which promoted 97±2% EC spreading similar to the 94±1% EC spreading observed on glass surface coated with untreated fibronectin. Thus, reptilase treatment did not decrease EC spreading on a coating of fibronectin, and the presence of fibronectin did not influence EC spreading on uncrosslinked fibrin prepared with either enzyme.
The marked difference in cell spreading on fibrin prepared with reptilase compared to that made with thrombin indicated that cleavage of FPB was required and suggested a role for the new amino terminus of the fibrin (3 chain that is exposed after FPB cleavage. To evaluate the role of the (3 chain amino terminus, protease III from Crotalus atrox venom was used to selectively remove residues 1-42 from the B(3 chain of fibrinogen. This modified fibrinogen (fibrinogen 325) mediated EC spreading ofadherent cells to the same degree as that seen using undegraded fibrinogen or fibrinogen containing supplemental fibronectin (30 ,g/ml) when coated on wells (not shown). Fibrinogen 325 was clotted by cleavage of FPA with either reptilase or with thrombin to form fibrin which lacked BB1-42 (fibrin 325). The structural modifications were confirmed by SDS PAGE (Fig. 5) , which showed that protease III selectively cleaved the BB chain to form fibrinogen 325. Fibrin 325 prepared with thrombin showed increased migration of the a chains consistent with cleavage of FPA. There was also cleavage ofFPB from the minor residual BB chain, and no change in migration of the ,B chain lacking residues 1-42. In contrast to the 70±5% spreading of EC adherent to fibrin made with thrombin from intact fibrinogen (Fig. 6) , only 19±5% ofadher- vWf was immunopurified from the cell lysates and culture medium and electrophoresed on SDS 2% agarose gels, and autoradiograms were prepared. Lysates of cells incubated in ammonium chloride showed only dimeric vWf and lacked the high molecular weight (HMW) multimers present in control cells. Similarly, the culture medium of control cells contained a full range of vWf multimers, whereas cells cultured in ammonium chloride showed concentrationdependent loss of all multimeric forms larger than dimer.
ing cell spreading, we prepared EC lacking Weibel-Palade bodies by culturing them for 3 d in ammonium chloride (5, 10, 25 mM) followed by immunofluorescence staining for vWf (Fig.  7) . Cells grown in the absence of ammonium chloride showed typical rod-shaped Weibel-Palade bodies (Fig. 7 a) , whereas they were absent in EC cultured in 25 mM ammonium chloride (Fig. 7 b) . Electrophoretic analysis of immunopurified, metabolically labeled vWf from EC lysates and media (Fig. 8) confirmed the absence of high molecular weight forms of vWf normally stored in Weibel-Palade bodies. Only vWf dimers were found in cell lysates and media of cells grown in ammonium chloride, whereas the full range of vWf multimers was found in controls. Despite the absence ofWeibel-Palade bodies and high molecular weight vWf, cells cultured in ammonium chloride showed a mean of 72% spreading (duplicate samples) on coverslips coated with thrombin-made fibrin. This was similar to the mean of 79% spreading (duplicate samples) on fibrin prepared with thrombin using untreated EC, indicating that the promotion of EC spreading associated with FPB cleavage was not dependent on stimulated release of vWf.
Discussion
Fibrins varying in structure at the amino-terminal ends of the Aa and B/3 chains were prepared to identify structural features needed to support EC spreading. The results indicate that EC spreading on uncross-linked fibrin requires cleavage of FPB and involves residues 15-42 of the ,B chain. Cells adhered but failed to spread on fibrin prepared with reptilase, a snake venom which cleaves FPA but not FPB, whereas EC spreading was high on fibrin prepared with thrombin, which cleaves both FPA and FPB. Fibrin prepared with both enzymes also supported cell spreading, indicating that reptilase was not inhibitory. Cell spreading on thrombin-made fibrin was not mediated by cleaved FPB incorporated into the fibrin clot, since fibrin prepared by reptilase cleavage of fibrinogen in a solution containing fibrinopeptides did not support EC spreading. The role ofthe new amino terminus ofthe 13 chain was investigated by using protease III from Crotalus atrox to specifically cleave B131-42 from fibrinogen, producing fibrinogen 325, lacking both FPB and 115-42. Fibrin prepared by thrombin cleavage of this modified fibrinogen supported minimal spreading, indicating that residues 15-42 ofthe 13 chain are needed to mediate spreading on a fibrin clot. The requirement for FPB cleavage to support spreading was not unique to EC but was also seen with cultured primary fibroblasts.
Several approaches were used to exclude the possibility that proteins other than fibrin contributed to the EC spreading observed on the fibrin surface. Plasma fibronectin, which was present in the original fibrinogen preparation, can mediate EC adhesion and spreading through an RGDS interaction with integrin a5#1 (31). Also, Grinnell and colleagues (32) reported that incorporation of fibronectin into fibrin was required for baby hamster kidney cell adhesion and spreading on a coating of fibrin, and factor XIIIa-mediated cross-linking of fibronectin into fibrin caused enhanced cell adhesion and spreading. However, we found that uncrosslinked fibrin prepared by thrombin cleavage of either fibronectin-depleted fibrinogen or fibronectin-depleted fibrinogen to which supplemental fibronectin (30 ,ug/ml) was added supported equal EC spreading. Also, fibronectin in fibrin prepared by reptilase in the absence ofcross-linking did not support EC spreading, even though the same concentration of fibronectin when used to coat a plastic surface did support spreading. Furthermore, addition of 0.5 U/ml reptilase to the fibronectin coating did not lower the high spreading observed on the fibronectin coated surface, indicating that reptilase did not adversely affect the site(s) on fibronectin responsible for mediating cell spreading. These results suggest that EC preferentially interact with the fibrin component ofa clot containing both fibrin and fibronectin, possibly due to the higher relative fibrin concentration. Moreover, this indicates that the presence of fibronectin in the absence of FPB cleavage was insufficient to support spreading.
Exposure of EC to enzymatically active thrombin at a concentration of0.1 U/ml (8 X 10-10 mol/liter) or greater has been shown to cause cell contraction (12, 33) , and a decrease in unpolymerized actin associated with increased formation of stress fibers was found after exposure to 2 U/ml (33) . In our cell spreading experiments, we prepared fibrin using a thrombin concentration of 0.5 U/ml, and < 1% bound to the surface, resulting in the incorporation of < 1 X l0-' mol (0.001 U) per well or slide. This is well below the concentrations observed to cause EC shape change and is also less than that needed to activate EC which occurs at concentrations of 0.01 U/ml or greater (34) (35) (36) (37) (38) (39) (40) (41) (Fig. 5 ).
We also investigated the possible role of other sites on the thrombin molecule, distinct from the thrombin catalytic center, in promoting spreading of EC on fibrin. The thrombin 13 chain has an RGD site at residues 187-189 preceded by a tyrosine at position 186 (45) . A thrombin derivative, formed by nitration of the tyrosine residue, has been shown to promote EC adhesion and spreading through av13 in an RGD-dependent manner, although native a-thrombin supported minimal adhesion (46) . To evaluate the possible role of the thrombin RGD site or other noncatalytic sites in mediating cell spreading, PPACK was used to inactivate the catalytic site, and the PPACK-thrombin complex was incorporated into fibrin made with reptilase. This fibrin surface failed to support spreading, indicating that neither the thrombin RGD site nor any other site distinct from the catalytic center was a sufficient stimulus.
Release of vWf from Weibel-Palade bodies of EC could potentially contribute to cell spreading on fibrin prepared with thrombin, since vWf release is stimulated from cells exposed on their nonadherent surface to fibrin (14) , possibly through recognition of 115-42 by a non-integrin receptor (47) . However, the difference in EC spreading observed on fibrin prepared with thrombin compared to that made with reptilase was maintained using EC depleted of Weibel-Palade bodies (Fig. 7  b) . Also, early passage fibroblasts, which do not synthesize vWf, spread on fibrin prepared with thrombin but not on fibrin prepared with reptilase, indicating that promotion of EC spreading by FPB cleavage and exposure of the new amino terminus of the 1 chain was not dependent on vWf release.
The adhesion of EC to fibrinogen is mediated through RGD sites that interact with the integrin receptor aS,03 (1, 48, 49) . The fibrinogen molecule has two RGD sequences on each Aa chain, one located in the central E-domain and a second near the Aa carboxyl terminus at residues 572-574. Cheresh et al. (48) have found that adhesion of EC to fibrinogen is mediated only by the carboxyl-terminal RGD site. Our results of adhesion on fibrin are consistent with this observation, since adhesion was equivalent on fibrin prepared with either reptilase or thrombin (Fig. 3) both of which had intact Aa chains (Fig. 4) . In contrast, the spreading ofEC on immobilized fibrinogen-coated surfaces appears to be mediated differently from EC spreading on fibrin. Fibrinogen immobilized on a plastic surface undergoes conformational changes exposing epitopes not accessible in soluble fibrinogen (49 The involvement of separate sites in mediating cell adhesion and spreading has been found with other adhesive glycoproteins including laminin and thrombospondin. For example, EC adherence to laminin is mediated through an RGD interaction with the integrin receptor a2#1 , but spreading results from interaction between the non-integrin receptor LB69 and the peptide sequence YIGRSR located on a separate polypeptide chain (2) . Additionally, the interaction of melanoma cells with thrombospondin involves two separate sites, with cell attachment mediated through an RGD containing carboxyl-terminal domain, while spreading requires an additional interaction with an amino-terminal heparin-binding domain (51) .
Cleavage of fibrinopeptides from fibrinogen by thrombin is a central event in hemostasis leading directly to fibrin polymerization. Cleavage of FPA occurs rapidly, exposes a polymerization site at the amino terminus of the a chain (52) , and can result in fibrin polymerization without FPB cleavage as demonstrated by the action of reptilase (53) . Cleavage of FPB by thrombin occurs more slowly (54, 55) , and exposes a secondary polymerization site that accelerates fibrin polymerization (56) and contributes to lateral organization of fibrin protofibrils (57) . Additionally cleavage of FPB exposes a fibrin specific epitope, 115-21, for which monoclonal antibodies have been identified (58, 59 ). More recent analysis indicates that the amino terminus of the fibrin 1 chain (#135-55) undergoes a significant conformational change after FPB cleavage, bringing noncontiguous amino acids into proximity and forming the polymerization site (56) . Thus, cleavage of fibrinopeptides not only results in formation of polymerized fibrin, but may also result in conformational changes and expose fibrin-specific sites important for modulation of cellular responses.
Peptides resulting from cleavage of the amino terminus of the B13 chain by thrombin or plasmin have been shown to exert several effects on cells involved in hemostasis and inflammation. FPB has been reported to have vasoconstrictor activity (60) , to stimulate migration of inflammatory cells including fibroblasts and neutrophils (61, 62) and to cause a change in EC morphology (63) . Plasmin hydrolyses the arg42-ala43 and the lys47-ala48 bonds, liberating the peptide B#13-42 from fibrinogen and , 135-42 from fibrin and also forming the small peptide 1343-47. The latter stimulates vasodilation and increased vascular permeability (60, 64, 65) . B#13-42 may stimulate cell migration (61, 62) , and B135-42 induces vWfrelease from EC (66) and also inhibits platelet aggregation (67 
